Top

On-Site Technical Deployment and Integration

Active

Federal

Response Deadline08/01/2026, 06:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJul 17

subcontract

Response DeadlineAug 1

Submission deadline

Response Deadline

08/01/2026, 06:00:00 PM UTCin 8 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Final setup, integration, and acceptance testing of the dual-unit HUMIMIC system at the FDA/CBER facility in Rockville, MD.

Similar Contracts

Same NAICS industry code

NAICS: 541714

New

Federal

Illumina Reagent Kits

Naval Medical Research Center

POSTED

DEADLINE

Battlefield Pain Management – AnalgesicThis solicitation under the Prototype Other Transaction Authority (10 U.S.C. § 4022) seeks innovative analgesic solutions for battlefield use, with the goal of achieving FDA approval for a single-use product intended to manage acute moderate to severe pain in combat settings. The product must be rapid to administer, compact in size and weight for individual carrying, and capable of functioning without refrigeration across extreme temperatures ranging from -25°C to 45°C while maintaining a 2-3 year shelf life at controlled room temperature. It must comply with USP <659> and MIL-STD-810 environmental standards, adhere to 21 CFR Part 820 quality system requirements for labeling and packaging, and meet strict physiological limits including no more than a 20% reduction in blood pressure, heart rate, or clotting ability, with only minor, non-ventilation-required airway changes. The product must be classified as a DEA Schedule II or higher controlled substance and may be delivered via nasal spray or autoinjector. The effort spans eight years, divided into three phases: three years for Chemistry Manufacturing Controls and stability studies, two years for non-clinical enabling studies, and three years for clinical trials and human factors testing culminating in potential EUA submission. The contract is structured as an Other Transaction Agreement exempt from FAR and DFARS, except where explicitly referenced, and is not subject to Bayh-Dole provisions. Proposals must demonstrate at least one of three pass/fail conditions: inclusion of a significant nontraditional defense contractor or nonprofit research institution, all non-federal participants being small businesses or nontraditional contractors, or at least one-third of project costs being privately funded. Evaluation focuses on technical approach, management strategy, and cost, with no assigned weights provided. Submission requires three clearly organized volumes in searchable PDF format, accompanied by a Microsoft Project plan, with strict formatting rules prohibiting embellishments. All participants must be registered in SAM with an active UEI and CAGE code, and must include NAICS code 541714. Compliance with prohibitions on malign foreign talent programs is mandatory, requiring certification and disclosure of foreign affiliations, ownerships, and funding sources. Payment occurs through WAWF using NPI, cost vouchers, or invoices tied to CLINs and ACRNs, with acceptance managed by an Agreement Officer Representative. Data deliverables, including CMC reports, clinical study outcomes, and regulatory filings, are governed by CDRL and DID attachments

Defense Health Agency

POSTED

DEADLINE

Development of Light-Responsive Artificial Cells using Plant-Based Photoreceptor SystemsThe United States Army Corps of Engineers Engineer Research and Development Center Construction Engineering Research Laboratory is seeking to develop light-responsive artificial cells by integrating plant-derived UVR8 photoreceptor systems into synthetic biology platforms, using high-throughput protein engineering and AI-assisted structural refinement to create programmable, pseudo-living systems activated by environmental light stimuli. The project aims to advance foundational science in synthetic biology by leveraging Bioconscientia, LLC’s uniquely specialized expertise in UVR8 photoreceptor technology, which enables precise sensing of UV-B light in a manner unmatched by other entities. Due to the highly specialized nature of the required research and Bioconscientia’s irreplaceable knowledge of existing experimental data and technical pathways, the government intends to award a sole-source contract to this vendor under RFO FAR 12.102(a), with an anticipated award date of September 30, 2026. This presolicitation notice, issued under FAR Part 5.101(a) with solicitation number W9132T26QA015 and NAICS code 541714, does not constitute a formal request for proposals or a competitive procurement, nor is it a set-aside. Interested parties may submit capability statements to CERL-CT-QUOTES@USACE.ARMY.MIL by July 31, 2026, to be reviewed for potential technical equivalency, but submission does not guarantee a change to the government’s acquisition strategy. The government retains full discretion to proceed with sole-source award regardless of responses received. All work will be performed in Champaign, Illinois, and the primary point of contact for submissions is Lurline L. Simmons, with Andrea J. Thomas serving as the contracting officer. No telephone inquiries will be accepted.

W2R2 Construction Engrg Labor

POSTED

DEADLINE

AI/ML and Data Analytics for Cardiovascular Device Validation

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)The Capability Program Executive for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND) is soliciting collaborative participation through a continuous, open Participant Basic Agreement (PBA) under the HEALER portfolio to advance next-generation, threat-agnostic host-directed therapeutics designed to enhance physiological resilience against CBRN threats. This initiative targets five critical biological systems—neurological protection, respiratory stabilization, immune modulation, hematologic and vascular function, and cellular stress and repair pathways—with the goal of developing dual-use medical countermeasures that serve both military and civilian critical care needs. The program invites two categories of collaborators: therapeutic developers with candidates that modulate host response mechanisms and drug development support providers including CROs and CDMOs with capabilities in preclinical testing, clinical trial execution, cGMP manufacturing, regulatory strategy, and advanced modeling. Submission requires a white paper of no more than five pages excluding a cover page, detailing product mechanism of action, efficacy data from validated animal models, regulatory status such as IND experience and clinical trial history, manufacturing capacity and scale-up plans, and company profile for therapeutic developers, or core capabilities and infrastructure for service providers. All participants must express willingness to collaborate with other PBA holders to foster an integrated development ecosystem. The solicitation, issued under statutory authority of 10 U.S.C. §§4021–4023, operates outside the Competition in Contracting Act and does not follow traditional procurement or evaluation frameworks, eliminating standard contract clauses, formal evaluation factors, pricing structures, or submission deadlines. Instead, awards are made at the government’s discretion through a non-traditional acquisition mechanism designed to accelerate innovation. Technical and administrative inquiries are directed to Hunter Robinson and Alexander Mayatte at the U.S. Army’s Aberdeen Proving Ground, Maryland office. Participation prerequisites include current registration in the System for Award Management (SAM), compliance with FDA regulatory pathways, and adherence to cGMP standards for manufacturing. While no specific delivery dates, FOB terms, inspection criteria, or cost estimates are defined, performance is expected to align with the mission of CPE CBRND to enable the Joint Force to operate effectively in CBRN-contested environments. Intellectual property considerations, teaming arrangements, and the scalability of therapeutic candidates are central to selection, with no socioeconomic or size status certifications required. The structure prioritizes agility, collaboration, and cross-sector innovation over rigid compliance, enabling a dynamic pipeline of medical countermeasures capable of addressing evolving biological threats through sustained host resilience.

POSTED

DEADLINE

Non-Optical Methods for High Speed Protein ControlDARPA’s Biological Technologies Office is seeking innovative solutions through the ERIS Marketplace to develop a new class of rapidly switchable, non-optogenetic protein domains capable of enabling real-time, massless control of cellular processes. The goal is to create a robust, modular molecular tool that responds to non-optical external signals such as magnetic fields or focused ultrasound, allowing precise regulation of protein function across cell membranes without relying on light or chemicals. Proposed solutions must achieve activation and deactivation kinetics of no more than two seconds, demonstrate reliable performance through at least 300 repetitive cycles in living cells, and function effectively in both split-protein dimerization and allosteric conformational configurations. This effort explicitly excludes any modifications or enhancements to existing optogenetic, light-based, or chemical systems. The anticipated contract value is $400,000 for a 12-month performance period, with awards being made on a rolling basis as solutions are evaluated, and the government reserves the right to issue awards before the December 8, 2026 submission deadline. Proposals must be submitted via the DARPA Connect ERIS Portal as a video that follows the required title format, or existing awardable solutions may be flagged for consideration by emailing ERIS@darpa.mil with specific subject and body requirements. Evaluation will focus on four core areas: a deep understanding of the problem space and current limitations in fields like sonogenetics and magnetogenetics, a significant technical leap in achieving rapid and repeatable protein control, demonstrated expertise in synthetic biology, protein engineering, and biophysics with a proven track record of quantitative in vivo characterization, and the potential of the solution to become a foundational tool in synthetic biology with broad applications in defense-relevant areas such as biomanufacturing, cell-based therapeutics, and biosensing. All submissions are subject to the ERIS assessment process, which serves as a mandatory pass/fail gate—only solutions deemed awardable by this process will be considered for BTO award. The procuring agency is the Department of Defense through DARPA’s Arlington, VA office, and all participants must comply with the ERIS Master Solicitation requirements available via SAM.gov.

Defense Advanced Research Projects Agcy

POSTED

DEADLINE

Notice of Intent to Sole Source – University of Maryland Medical Center

National Institutes Of Health - Cc

POSTED

DEADLINE

Limited Competition: Clinical and Translational Science Awards (CTSA) Program: Collaborative and Innovative Acceleration AwardThe Congressionally mandated Clinical and Translational Science Awards (CTSA) Program aims to accelerate the translation of scientific discoveries into practical treatments, diagnostics, and health interventions that enhance patient and public health by funding a national network of academic medical centers. This network provides essential infrastructure, expertise, training, and collaborative platforms needed to move research from the laboratory into clinical practice and community health settings. The current opportunity is a forecast for a limited competition soliciting applications for the Collaborative and Innovative Acceleration Award, designed to support the development and implementation of novel approaches, technologies, or models that amplify the impact of translational research and expedite the delivery of effective therapies to all populations. Funding is authorized under Sections 301 and 405 of the Public Health Service Act, and governed by Federal Regulations 42 CFR Part 52 and 2 CFR Part 200. Eligible organizations may apply under this limited competition, and proposals will undergo standard National Institutes of Health peer review, with funding awarded only to meritorious applications. The announcement is issued by the National Institutes of Health, under the Department of Health and Human Services, with specific inquiries directed to the Division of Clinical Innovation at NCATS. The forecast was posted on July 20, 2026, and further details can be accessed through the official grants.gov listing, though no set-aside type, NAICS code, or specific place of performance is indicated.

National Institutes Of Health

POSTED

DEADLINE

Hypoxia Chamber ServicesNASA Johnson Space Center is soliciting offers for Hypoxia Chamber Services under solicitation number 80JSC026Q0008 to support research on the physiological, cognitive, and clinical effects of mild hypobaric hypoxia as part of the Artemis Program. The contract requires comprehensive services including infrastructure, personnel, training, materials, food, supplies, and operational support necessary to conduct controlled hypoxia experiments. This is a combined synopsis and solicitation issued under FAR Subpart 12.6, with no written solicitation to follow, and all information is contained within the posted notice and attachments, particularly Attachment A for the Performance Work Statement and Attachment D for additional submission requirements. The NAICS code is 541714 with a size standard of 1,000 employees, and offerors must self-certify their size status. Evaluation will prioritize Technical Acceptability and Past Performance as significantly more important than Price, though Price becomes increasingly relevant when proposals are closely matched in technical merit. All submissions must include completed representations and certifications per FAR 52.212-3 and comply fully with FAR 52.212-1 and 52.212-4. Proposals must be submitted electronically via email to the designated NASA contacts no later than 1:00 PM CST on August 24, 2026, with questions due by July 29, 2026. The Government assumes no responsibility for electronic submission failures, and late submissions will be rejected per FAR provisions. The place of performance is Houston, Texas, and the Ombudsman clause is applicable for dispute resolution.

NASA Johnson Space Center

POSTED

DEADLINE

Elucidation and Validation of the role of Transporters in the Placenta, Lactating Mammary Gland, Developing Gut, and Blood Brain BarrierThe Eunice Kennedy Shriver National Institute of Child Health and Human Development is advancing its mission to improve maternal, fetal, and child health by launching a second phase of the Transporter Elucidation Network, focused on understanding how biological transporters and local metabolic processes regulate exposure to nutrients, medications, microbiome-derived compounds, and environmental chemicals across critical perinatal barriers. This initiative will develop comprehensive multi-barrier frameworks that connect the maternal gut, placenta, lactating mammary epithelium, infant gut, and infant blood-brain barrier, building on prior organ-specific research to create standardized models, resources, and prototype multi-compartment systems that reflect the dynamic interplay of transporters, their polarity, kinetics, and biotransformation capacities during pregnancy, lactation, and infant development. The goal is to deepen mechanistic insights into how these systems influence nutrient delivery, drug distribution, and neurodevelopmental outcomes in early life. This phase will establish community-wide resources to support integrated studies of perinatal exposure, risk assessment, and targeted interventions across linked maternal-fetal-infant systems, while strengthening collaboration among researchers and accelerating the sharing of tools and data. Emphasis is placed on human-based and developmentally relevant models to ensure biological accuracy and translational impact. The effort also aims to cultivate a next-generation workforce skilled in transporter science, fostering innovation in pediatric pharmacology and neonatal health. Authorized under 42 U.S.C. § 241, the initiative is being led by the Obstetric and Pediatric Pharmacology and Therapeutics Branch of NICHD, with inquiries directed to their designated point of contact, and the opportunity was publicly forecasted on July 16, 2026.

National Institutes Of Health

POSTED

DEADLINE

Advanced Prebreathe and Thermal Monitoring Studies

NASA Johnson Space Center

POSTED

DEADLINE

Hypobaric Chamber Pilot StudiesNASA Johnson Space Center is soliciting offers for pilot chamber testing facilities capable of conducting hypobaric Decompression Sickness (DCS) studies under solicitation number 80JSC026Q0006, issued as a combined synopsis and solicitation per FAR Part 12 for commercial products and services. The requirement calls for three test days of data collection and recording following established research protocols, with detailed specifications outlined in Attachment A – Statement of Work and additional submission criteria in Attachment D dated July 15, 2026. The solicitation is open to all responsible sources without set-aside restrictions, and offerors must declare their size status under NAICS code 541714 with a 1,000-employee size standard. Evaluation of proposals will prioritize technical acceptability, followed by past performance, and then price, as specified in FAR 52.212-2. Offers must comply with applicable clauses including FAR 52.212-1, 52.212-2, and 52.212-4, as well as NASA-specific clauses such as the Ombudsman provision. All submissions must be delivered electronically to Tracy.L.Quintanilla@nasa.gov and Katelyn.R.Jaime@nasa.gov no later than August 24, 2026, at 1:00 p.m. Central Time. Questions must be submitted via email by July 29, 2026, same time, with no telephone inquiries accepted. Prospective offerors are encouraged to notify the point of contact of their intent to respond, and it is the offeror’s responsibility to download all documents from SAM.gov and ensure timely submission, as late or incomplete offers will be rejected in accordance with FAR provisions.

NASA Johnson Space Center

POSTED

9 days ago

DEADLINE

in about 1 month

View Details

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

Surgical Appliance and Supplies Manufacturing

POSTED

DEADLINE

FDA Subcutaneous Injection Site Simulator (SCISSOR)

Analytical Laboratory Instrument Manufacturing

POSTED

DEADLINE

National Center for Toxicological Research (NCTR) on-site facility Operations and Maintenance (O&M) support servicesThe National Center for Toxicological Research (NCTR) in Jefferson, Arkansas is seeking a small business contractor to provide comprehensive on-site Operations and Maintenance (O&M) support services for its multi-building research facility, which includes animal care and laboratory operations, as well as facilities under construction. The contract is structured as a hybrid model, combining Firm-Fixed-Price (FFP) requirements for routine O&M tasks with an Indefinite Delivery Indefinite Quantity (IDIQ) component for additional work, with a maximum IDIQ value of $5,000,000 over a five-year ordering period. Performance spans a 20-day Phase-In period from September 1 to September 20, 2026, followed by a one-year Base Period and four Option Periods extending through September 20, 2031. Key deliverables include routine facility maintenance, electrical system operations, grounds upkeep, pest control for specific buildings, and a comprehensive Preventive Maintenance Program. All services must operate 24/7, 365 days a year, with critical systems held to a 99% Acceptable Quality Level (AQL). The contractor must adhere to strict packaging standards, prohibiting materials like asbestos, excelsior, newspaper, and loose fill polystyrene, and must supply detailed Plans including Quality Control, Safety and Health, Emergency Procedures, Strike Contingency, and Pest Control within specified timeframes after award. Personnel must be qualified, licensed as required, and comply with federal security protocols, including background checks and signing the FDA Commitment to Protect Non-Public Information Agreement. The solicitation, identified as 75F40126R00051, is a Total Small Business Set-Aside under NAICS code 561210 with a size standard of $47 million, requiring offerors to be small businesses as defined by the SBA. Proposals must be submitted in separate Business and Technical volumes, with the Technical Proposal limited to 30 pages and structured to reflect the Performance Work Statement’s sequence, avoiding pricing details but including labor categories and resource plans. Past Performance must include three to five relevant contracts within the past three years, accompanied by completed evaluation questionnaires and client letters delivered directly to the Contract Specialist. Offerors must demonstrate high confidence in their Technical Approach, Key Personnel qualifications, and Staffing Plan, with evaluation emphasizing technical merit and past performance as significantly more important than price. The Government will not

Facilities Support Services

POSTED

DEADLINE

High Purity Germanium Gamma-Ray Spectrometer

Analytical Laboratory Instrument Manufacturing

POSTED

DEADLINE

FDA Third Party Tobacco Retailer Inspection Services (Region 4)The U.S. Food and Drug Administration is soliciting third-party services to conduct tobacco retailer compliance inspections across Region 4, which includes Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming. This Indefinite Delivery/Indefinite Quantity (IDIQ) contract, issued under solicitation number 75F40126R00040, has a five-year ordering period with task orders typically lasting 12 months and an estimated total value ranging from $10,000 to $33,500,000. The contractor is responsible for providing all personnel, management, and logistical support to perform undercover buy and advertising and labeling inspections in accordance with the Federal Food, Drug, and Cosmetic Act and FDA protocols. All inspectors must be commissioned as officers of the U.S. Department of Health and Human Services under Section 702(a)(1)(A) of the FD&C Act prior to conducting any inspections. The contract includes support for evidence handling, reporting, program management, and cost-reimbursable witness testimony. Pricing for most task orders is firm-fixed-price, with cost reimbursement reserved for specific items including non-inspection travel, other direct costs, and legal support. The procurement is a 100% Small Business Set-Aside under NAICS code 561611, requiring all offerors to be registered in SAM.gov at both submission and award stages. Performance is anchored in Rockville, Maryland, with the primary point of contact being Jennifer Mun of the FDA Office of Acquisitions and Grant Services, and responses are due by July 31, 2026.

Investigation and Personal Background Check Services

POSTED

DEADLINE

FDA Preventive Maintenance-Repair Agreement for Revvity Spectrum IVIS system

Electronic and Precision Equipment Repair and Maintenance

POSTED

DEADLINE

Spare Parts Supply for Nitrogen GeneratorsThe contract is for the supply of OEM-compliant replacement parts including filters, compressors, sensors, and software licenses for SLO and NG series nitrogen generators to support ongoing maintenance at five FDA laboratories. These components are critical to ensuring the reliable operation of nitrogen generation systems used in regulated laboratory environments, where uninterrupted performance is necessary for compliance and data integrity. All parts must meet original equipment manufacturer specifications to maintain system certification and regulatory alignment under FDA oversight. This is a total small business set-aside under SBA guidelines, reserved exclusively for small businesses as defined by the NAICS code 423830, which pertains to industrial machinery and equipment merchant wholesalers. The opportunity was posted on July 22, 2026, with a response deadline of August 5, 2026, and performance is expected to occur in Miami, Florida, where the FDA’s operational facilities are located. The contract is structured as a subcontract within the Department of Health and Human Services’ procurement framework, managed by the FDA Office of Acquisition and Grant Services.

Industrial Machinery and Equipment Merchant Wholesalers

POSTED

DEADLINE

Emergency Breakdown and Repair Services for Nitrogen GeneratorsThe contract mandates the provision of 24/7 emergency response services for nitrogen generator failures across all five FDA sites, ensuring that qualified technicians arrive on-site within 48 hours of notification to diagnose, repair, and fully restore system functionality. The service must maintain uninterrupted operational capacity critical to FDA mission-critical processes, with response protocols designed to minimize downtime and comply with stringent regulatory requirements. The contractor is expected to demonstrate proven experience in high-stakes industrial maintenance environments and possess the technical capability to address complex failures under time-sensitive conditions. This is a small business set-aside subcontract under NAICS code 811212, issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, with performance centered in Miami, Florida. The solicitation opened on July 22, 2026, and responses are due by August 5, 2026, at 5:00 p.m. The emphasis is on reliability, rapid turnaround, and sustained system integrity, requiring the contractor to support mission continuity across multiple geographically dispersed facilities with consistent, high-quality service delivery.

Computer and Office Machine Repair and Maintenance

POSTED

DEADLINE

Preventive Maintenance for SLO HoriZen 24 Nitrogen GeneratorsThe contract requires annual preventive maintenance services for SLO HoriZen 24 nitrogen generators located at five FDA laboratories, with scope including diagnostic evaluations, replacement of critical filters, pressure testing to ensure system integrity, and necessary firmware updates to maintain optimal performance. Services must be performed in accordance with established protocols to support the consistent operation of these critical laboratory instruments, which are vital to regulatory and scientific processes within the FDA. The work will be conducted at a designated location in Miami, Florida, with all maintenance activities tailored to meet the operational demands of a federally regulated environment. This is a subcontract under a Total Small Business Set-Aside, meaning only small businesses as defined by the Small Business Administration are eligible to respond. The solicitation was posted on July 22, 2026, with a response deadline of August 5, 2026. The North American Industry Classification System code 811212 classifies the service under appliance repair and maintenance, reflecting the technical nature of the work. The contracting activity falls under the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services, and all performance must comply with federal standards for scientific equipment maintenance and documentation.

Computer and Office Machine Repair and Maintenance

POSTED

DEADLINE

Preventive Maintenance for NG3000A Nitrogen GeneratorsThe contract requires scheduled preventive maintenance services for NG3000A nitrogen generators located at five FDA sites, with tasks including comprehensive compressor inspections, oil changes, sensor calibration, and software updates to ensure optimal performance and regulatory compliance. All work must be performed in accordance with industry standards and FDA requirements, with a focus on minimizing downtime and maintaining consistent nitrogen output essential for laboratory and manufacturing operations. The solicitation is designated as a Total Small Business Set-Aside under SBA guidelines, exclusively available to small businesses as defined by the NAICS code 811212 for industrial and commercial laundry and drycleaning services, which includes maintenance and repair of industrial equipment. The opportunity was posted on July 22, 2026, with a response deadline of August 5, 2026, and the primary place of performance is in Miami, Florida, though services will extend to four additional FDA locations. The contracting activity falls under the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services.

Computer and Office Machine Repair and Maintenance

POSTED

DEADLINE

Preventive Maintenance for SLO Genius SQ 24 Nitrogen GeneratorsThe contract requires annual or bi-annual on-site preventive maintenance for SLO Genius SQ 24 nitrogen generators located at five FDA laboratories, with services including thorough inspection, calibration, filter replacement, and performance verification to ensure consistent operation and compliance with regulatory standards. All work must be performed at the designated facility in Miami, Florida, with a focus on maintaining the integrity and reliability of the nitrogen generation systems critical to laboratory functions. This is a total small business set-aside under the SBA program, specifically targeted toward small businesses as defined by FAR 19.5, with the NAICS code 811212 indicating a focus on industrial and commercial machinery and equipment repair and maintenance. The solicitation was posted on July 22, 2026, with a response deadline of August 5, 2026, and is structured as a subcontract under the Department of Health and Human Services, Office of Acquisition and Grant Services. The contract aims to secure qualified small business vendors capable of delivering timely, high-quality maintenance services to support FDA’s operational needs.

Computer and Office Machine Repair and Maintenance

POSTED

DEADLINE

Section 508 Accessibility Compliance and RemediationThe contract requires the preparation of Accessibility Conformance Reports using the Voluntary Product Accessibility Template for all information and communication technology components, ensuring full compliance with Section 508 standards. All non-compliant software or user interfaces must be remediated at no extra cost to the government, with the vendor responsible for identifying accessibility barriers and implementing necessary fixes to meet federal accessibility requirements. The work is tied to a subcontract under the FDA Office of Acquisition and Grant Services, part of the Department of Health and Human Services, with performance based in Cincinnati, Ohio, 45237. The solicitation was posted on July 22, 2026, with responses due by August 6, 2026, and falls under NAICS code 541512 for Computer Systems Design Services. There is no set-aside designation specified, and the contract does not include a designated point of contact. The vendor must deliver accurate, comprehensive accessibility documentation and ensure all remediation efforts meet federal compliance mandates without additional billing to the government, making cost-efficiency and technical precision critical to fulfillment.

Computer Systems Design Services

POSTED

2 days ago

DEADLINE

in 13 days

View Details